Literature DB >> 903399

Adrenal suppression with aminoglutethimide. II. Differential effects of aminoglutethimide on plasma androstenedione and estrogen levels.

E Samojlik, R J Santen, S A Wells.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 903399     DOI: 10.1210/jcem-45-3-480

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  10 in total

Review 1.  Recent advances in studies on estrogen biosynthesis.

Authors:  A M Brodie
Journal:  J Endocrinol Invest       Date:  1979 Oct-Dec       Impact factor: 4.256

2.  Medical adrenalectomy with aminoglutethimide: clinical studies in postmenopausal patients with metastatic breast carcinoma.

Authors:  S A Wells; R J Santen; A Lipton; D E Haagensen; E J Ruby; H Harvey; W G Dilley
Journal:  Ann Surg       Date:  1978-05       Impact factor: 12.969

Review 3.  Comprehensive pharmacology and clinical efficacy of aromatase inhibitors.

Authors:  V C Njar; A M Brodie
Journal:  Drugs       Date:  1999-08       Impact factor: 9.546

Review 4.  Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer.

Authors:  V Craig Jordan; Angela M H Brodie
Journal:  Steroids       Date:  2006-12-13       Impact factor: 2.668

Review 5.  Suppression of estrogens with aminoglutethimide and hydrocortisone (medical adrenalectomy) as treatment of advanced breast carcinoma: a review.

Authors:  R J Santen
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

Review 6.  Preservation of androgen secretion during estrogen suppression with aminoglutethimide in the treatment of metastatic breast carcinoma.

Authors:  E Samojlik; J D Veldhuis; S A Wells; R J Santen
Journal:  J Clin Invest       Date:  1980-03       Impact factor: 14.808

Review 7.  Aromatase and its inhibitors in breast cancer treatment--overview and perspective.

Authors:  A M Brodie; R J Santen
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 8.  Treatment of breast cancer with aromatase inhibitors--current status and future prospects.

Authors:  P E Lønning; M Dowsett; T J Powles
Journal:  Br J Cancer       Date:  1989-07       Impact factor: 7.640

9.  Alterations in the production rate and the metabolism of oestrone and oestrone sulphate in breast cancer patients treated with aminoglutethimide.

Authors:  P E Lønning; D C Johannessen; T Thorsen
Journal:  Br J Cancer       Date:  1989-07       Impact factor: 7.640

10.  Endocrinological and clinical evaluation of two doses of formestane in advanced breast cancer.

Authors:  E Bajetta; N Zilembo; R Buzzoni; C Noberasco; A Di Leo; C Bartoli; M Merson; V Sacchini; D Moglia; L Celio
Journal:  Br J Cancer       Date:  1994-07       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.